The University of Chicago Header Logo

Ann Marie Mauer

Title
InstitutionUniversity of Chicago
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Muss HB, Polley MC, Berry DA, Liu H, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Kartcheske PA, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Sutton LM, Magrinat G, Parker BA, Hart RD, Grenier D, Hurria A, Jatoi A, Norton L, Hudis CA, Winer EP, Carey L, Muss HB, Polley MC, Berry DA, Liu H, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Kartcheske PA, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Sutton LM, Magrinat G, Parker BA, Hart RD, Grenier D, Hurria A, Jatoi A, Norton L, Hudis CA, Winer EP, Carey L. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 09 10; 37(26):2338-2348. PMID: 31339827; PMCID: PMC6900836.
      Citations: 20     Fields:    Translation:Humans
    2. Chillo O, Kleinert EC, Lautz T, Lasch M, Pagel JI, Heun Y, Troidl K, Fischer S, Caballero-Martinez A, Mauer A, Kurz ARM, Assmann G, Rehberg M, Kanse SM, Nieswandt B, Walzog B, Reichel CA, Mannell H, Preissner KT, Deindl E, Chillo O, Kleinert EC, Lautz T, Lasch M, Pagel JI, Heun Y, Troidl K, Fischer S, Caballero-Martinez A, Mauer A, Kurz ARM, Assmann G, Rehberg M, Kanse SM, Nieswandt B, Walzog B, Reichel CA, Mannell H, Preissner KT, Deindl E. Perivascular Mast Cells Govern Shear Stress-Induced Arteriogenesis by Orchestrating Leukocyte Function. Cell Rep. 2016 08 23; 16(8):2197-2207. PMID: 27524614.
      Citations: 31     Fields:    Translation:AnimalsCells
    3. Choong NW, Mauer AM, Haraf DC, Ferguson MK, Sandler AB, Kesler KA, Fishkin PA, Ansari RH, Wade J, Krauss SA, Sciortino DF, Posner MC, Kocherginsky M, Hoffman PC, Szeto L, Vokes EE, Choong NW, Mauer AM, Haraf DC, Ferguson MK, Sandler AB, Kesler KA, Fishkin PA, Ansari RH, Wade J, Krauss SA, Sciortino DF, Posner MC, Kocherginsky M, Hoffman PC, Szeto L, Vokes EE. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61. PMID: 20730572.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    4. Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Magrinat G, Magrinat G, Parker BA, Hart RD, Grenier D, Norton L, Hudis CA, Winer EP, Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Magrinat G, Magrinat G, Parker BA, Hart RD, Grenier D, Norton L, Hudis CA, Winer EP, CALGB Investigators. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14; 360(20):2055-65. PMID: 19439741; PMCID: PMC3082436.
      Citations: 184     Fields:    Translation:Humans
    5. Kim ES, Mauer AM, William WN, Tran HT, Liu D, Lee JJ, Windt P, Hong WK, Vokes EE, Herbst RS, Kim ES, Mauer AM, William WN, Tran HT, Liu D, Lee JJ, Windt P, Hong WK, Vokes EE, Herbst RS. A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer. Cancer. 2009 Apr 15; 115(8):1713-22. PMID: 19208430; PMCID: PMC5142442.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    6. Stinchcombe TE, Mauer AM, Hodgson LD, Herndon JE, Lynch TJ, Green MR, Vokes EE, Stinchcombe TE, Mauer AM, Hodgson LD, Herndon JE, Lynch TJ, Green MR, Vokes EE, Cancer and Leukemia Group B. Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430. J Thorac Oncol. 2008 Nov; 3(11):1301-7. PMID: 18978566; PMCID: PMC2696476.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    7. Choong NW, Mauer AM, Haraf DJ, Lester E, Hoffman PC, Kozloff M, Lin S, Dancey JE, Szeto L, Grushko T, Olopade OI, Salgia R, Vokes EE, Choong NW, Mauer AM, Haraf DJ, Lester E, Hoffman PC, Kozloff M, Lin S, Dancey JE, Szeto L, Grushko T, Olopade OI, Salgia R, Vokes EE. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11. PMID: 18758303; PMCID: PMC4535721.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    8. Mauer AM, Cohen EE, Ma PC, Kozloff MF, Schwartzberg L, Coates AI, Qian J, Hagey AE, Gordon GB, Mauer AM, Cohen EE, Ma PC, Kozloff MF, Schwartzberg L, Coates AI, Qian J, Hagey AE, Gordon GB. A phase II study of ABT-751 in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2008 Jun; 3(6):631-6. PMID: 18520803.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    9. Edelman MJ, Watson D, Wang X, Morrison C, Kratzke RA, Jewell S, Hodgson L, Mauer AM, Gajra A, Masters GA, Bedor M, Vokes EE, Green MJ, Edelman MJ, Watson D, Wang X, Morrison C, Kratzke RA, Jewell S, Hodgson L, Mauer AM, Gajra A, Masters GA, Bedor M, Vokes EE, Green MJ. Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. J Clin Oncol. 2008 Feb 20; 26(6):848-55. PMID: 18281656.
      Citations: 93     Fields:    Translation:HumansCellsCTClinical Trials
    10. Choong NW, Vokes EE, Haraf DJ, Tothy PK, Ferguson MK, Kasza K, Rudin CM, Hoffman PC, Krauss SA, Szeto L, Mauer AM, Choong NW, Vokes EE, Haraf DJ, Tothy PK, Ferguson MK, Kasza K, Rudin CM, Hoffman PC, Krauss SA, Szeto L, Mauer AM. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67. PMID: 18166842; PMCID: PMC3742080.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    11. Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EE, Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EE. A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer. Cancer Invest. 2007 Sep; 25(6):435-44. PMID: 17882655.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    12. Buckingham LE, Coon JS, Morrison LE, Jacobson KK, Jewell SS, Kaiser KA, Mauer AM, Muzzafar T, Polowy C, Basu S, Gale M, Villaflor VM, Bonomi P, Buckingham LE, Coon JS, Morrison LE, Jacobson KK, Jewell SS, Kaiser KA, Mauer AM, Muzzafar T, Polowy C, Basu S, Gale M, Villaflor VM, Bonomi P. The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib. J Thorac Oncol. 2007 May; 2(5):414-22. PMID: 17473657.
      Citations: 14     Fields:    Translation:HumansCells
    13. Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE, Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):515-22. PMID: 17255273.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    14. Mauer AM, Rich ES, Schilsky RL, Mauer AM, Rich ES, Schilsky RL. The role of cooperative groups in cancer clinical trials. Cancer Treat Res. 2007; 132:111-29. PMID: 17305018.
      Citations: 2     Fields:    Translation:Humans
    15. Choong NW, Mauer AM, Hoffman PC, Rudin CM, Winegarden JD, Villano JL, Kozloff M, Wade JL, Sciortino DF, Szeto L, Vokes EE, Choong NW, Mauer AM, Hoffman PC, Rudin CM, Winegarden JD, Villano JL, Kozloff M, Wade JL, Sciortino DF, Szeto L, Vokes EE. Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):245-51. PMID: 17409864.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    16. Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE, Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24. PMID: 16322304.
      Citations: 74     Fields:    Translation:HumansCTClinical Trials
    17. Mauer AM, Szeto L, Belt RJ, Schwartzberg LS, Hagey A, Coates AI, Meek KA, Cernohous P, Gordon GB. Preliminary results of a phase 2 study of ABT-751 in patients (pts) with taxane-refractory non-small cell lung carcinoma (NSCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):7137. PMID: 27944957.
      Citations:    
    18. Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Obasaju C, Haraf DJ, Salgia R, Vokes EE. A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):7062. PMID: 27944519.
      Citations:    
    19. Villaflor VM, Buckingham L, Gale M, Coon J, Mauer AM, Muzzafar T, Kaiser K, Zusag TW, Faber LP, Bonomi P. EGFR mutations and pAKT expression as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol. 2005 Jun; 23(16_suppl):7077. PMID: 27944528.
      Citations:    
    20. Vokes EE, Cohen EE, Mauer AM, Karrison TG, Wong SJ, Skoog-Sluman LJ, Kozloff MF, Dancey J, Dekker A. A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC). J Clin Oncol. 2005 Jun; 23(16_suppl):5504. PMID: 27945465.
      Citations:    
    21. Hoffman PC, Mauer AM, Haraf DC, Lester EP, Szeto LL, Vokes EE. A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):7113. PMID: 27944213.
      Citations:    
    22. Cohen EE, Haraf DJ, Stenson KM, Blair E, Brockstein BE, Mauer AM, Dekker A, Williams R, Lester E, Vokes EE. Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial. J Clin Oncol. 2005 Jun; 23(16_suppl):5506. PMID: 27945467.
      Citations:    
    23. Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, Vokes EE, Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, Vokes EE. Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol. 2005 Aug; 16(8):1320-5. PMID: 15919687.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    24. Gupta S, Mauer AM, Ryan CW, Taber DA, Samuels BL, Fleming GF, Gupta S, Mauer AM, Ryan CW, Taber DA, Samuels BL, Fleming GF, University of Chicago Phase II Network. A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer. Am J Clin Oncol. 2005 Feb; 28(1):65-9. PMID: 15685037.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    25. Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR, Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83. PMID: 15547705.
      Citations: 43     Fields:    Translation:HumansCTClinical Trials
    26. Undevia SD, Vogelzang NJ, Mauer AM, Janisch L, Mani S, Ratain MJ, Undevia SD, Vogelzang NJ, Mauer AM, Janisch L, Mani S, Ratain MJ. Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs. 2004 Nov; 22(4):449-58. PMID: 15292715.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    27. Winegarden JD, Mauer AM, Otterson GA, Rudin CM, Villalona-Calero MA, Lanzotti VJ, Szeto L, Kasza K, Hoffman PC, Vokes EE, Winegarden JD, Mauer AM, Otterson GA, Rudin CM, Villalona-Calero MA, Lanzotti VJ, Szeto L, Kasza K, Hoffman PC, Vokes EE, University of Chicago Phase II Network, Ohio State University. A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Ann Oncol. 2004 Jun; 15(6):915-20. PMID: 15151948.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    28. Mauer AM, Ansari RH, Hoffman PC, Krauss SA, Taber D, Tembe SA, Gabrys GT, Cotter T, Schumm LP, Szeto L, Vokes EE, Mauer AM, Ansari RH, Hoffman PC, Krauss SA, Taber D, Tembe SA, Gabrys GT, Cotter T, Schumm LP, Szeto L, Vokes EE. Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer. Ann Oncol. 2003 May; 14(5):722-8. PMID: 12702526.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    29. Villano JL, Mauer AM, Vokes EE, Villano JL, Mauer AM, Vokes EE. A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain. Ann Oncol. 2003 Apr; 14(4):656-8. PMID: 12649117.
      Citations: 5     Fields:    Translation:Humans
    30. Winegarden JD, Mauer AM, Gajewski TF, Hoffman PC, Krauss S, Rudin CM, Vokes EE, Winegarden JD, Mauer AM, Gajewski TF, Hoffman PC, Krauss S, Rudin CM, Vokes EE. A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):191-6. PMID: 12581572.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    31. Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EE, Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EE. Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study. Lung Cancer. 2002 Oct; 38(1):65-71. PMID: 12367795.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    32. Vokes EE, Charoentum C, Gordon GS, Rudin CM, Krauss SA, Hoffman PC, Mauer AM, Lee S, Watson S, Vokes EE, Charoentum C, Gordon GS, Rudin CM, Krauss SA, Hoffman PC, Mauer AM, Lee S, Watson S. Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer. Clin Lung Cancer. 2002 May; 3(4):265-70. PMID: 14662035.
      Citations:    Fields:    
    33. Rudin CM, Otterson GA, Mauer AM, Villalona-Calero MA, Tomek R, Prange B, George CM, Szeto L, Vokes EE, Rudin CM, Otterson GA, Mauer AM, Villalona-Calero MA, Tomek R, Prange B, George CM, Szeto L, Vokes EE. A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer. Ann Oncol. 2002 Apr; 13(4):539-45. PMID: 12056703.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    34. Eng C, Mauer AM, Fleming GF, Bertucci D, Rotmensch J, Jacobs RH, Ratain MJ, Eng C, Mauer AM, Fleming GF, Bertucci D, Rotmensch J, Jacobs RH, Ratain MJ. Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors. Ann Oncol. 2001 Dec; 12(12):1743-7. PMID: 11843253.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    35. Vokes EE, Gordon GS, Rudin CM, Mauer AM, Watson S, Krauss S, Arrieta R, Golomb HM, Hoffman PC, Vokes EE, Gordon GS, Rudin CM, Mauer AM, Watson S, Krauss S, Arrieta R, Golomb HM, Hoffman PC. A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer. Invest New Drugs. 2001; 19(4):329-33. PMID: 11561694.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    36. George CM, Haraf DJ, Mauer AM, Krauss SA, Hoffman PC, Rudin CM, Szeto L, Vokes EE, George CM, Haraf DJ, Mauer AM, Krauss SA, Hoffman PC, Rudin CM, Szeto L, Vokes EE. A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest. Invest New Drugs. 2001; 19(4):303-10. PMID: 11561689.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    37. Vokes EE, Gordon GS, Mauer AM, Rudin CM, Krauss SA, Szeto L, Golomb HM, Hoffman PC, Vokes EE, Gordon GS, Mauer AM, Rudin CM, Krauss SA, Szeto L, Golomb HM, Hoffman PC. A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer. Clin Lung Cancer. 2000 Nov; 2(2):128-32. PMID: 14731323.
      Citations: 3     Fields:    
    38. Hoffman PC, Mauer AM, Vokes EE, Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000 Feb 05; 355(9202):479-85. PMID: 10841143.
      Citations: 264     Fields:    Translation:Humans
    39. Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BW, Shammo JM, Calhoun B, Mauer AM, Hoffman PC, Baron JM, Baron BW. First two cases of immune hemolytic anemia associated with ceftizoxime. Transfusion. 1999 Aug; 39(8):838-44. PMID: 10504119.
      Citations: 2     Fields:    Translation:Humans
    40. Flamholz R, Tran T, Grad GI, Mauer AM, Olopade OI, Ellman MH, McKinsey JF, Jeon HR, Baron JM, Baron BW, Flamholz R, Tran T, Grad GI, Mauer AM, Olopade OI, Ellman MH, McKinsey JF, Jeon HR, Baron JM, Baron BW. Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapy. J Clin Apher. 1999; 14(4):171-6. PMID: 10611626.
      Citations: 6     Fields:    Translation:Humans
    41. Haase GM, Mauer AM, Reaman GH, Haase GM, Mauer AM, Reaman GH. Survivorship in childhood cancer: a case statement for enhancement of the role of the American Cancer Society. Task Force on Children and Cancer of the American Cancer Society. Cancer. 1998 Aug 15; 83(4):821-3. PMID: 9708952.
      Citations: 1     Fields:    Translation:Humans
    42. Vokes EE, Mauer AM, Vokes EE, Mauer AM. Multimodality therapy for esophageal cancer: an emerging role. Cancer J Sci Am. 1998 Jul-Aug; 4(4):226-9. PMID: 9689980.
      Citations:    Fields:    Translation:Humans
    43. Masters GA, Mauer AM, Hoffman PC, Wyka D, Samuels BL, Krauss SA, Watson S, Golomb H, Vokes EE, Masters GA, Mauer AM, Hoffman PC, Wyka D, Samuels BL, Krauss SA, Watson S, Golomb H, Vokes EE. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80. PMID: 9681085.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    44. Vokes EE, Mauer AM, Hoffman PC, Haraf DJ, Vokes EE, Mauer AM, Hoffman PC, Haraf DJ. Combined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy. Semin Oncol. 1998 Jun; 25(3 Suppl 8):28-32. PMID: 9704674.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    45. Vokes EE, Masters GA, Mauer AM, Hoffman PC, Watson S, Golomb HM, Vokes EE, Masters GA, Mauer AM, Hoffman PC, Watson S, Golomb HM. Ifosfamide-based three-drug combination regimens in non-small cell lung cancer. Semin Oncol. 1998 Feb; 25(1 Suppl 2):19-22. PMID: 9535207.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    46. Mauer AM, Masters GA, Haraf DJ, Hoffman PC, Watson SM, Golomb HM, Vokes EE, Mauer AM, Masters GA, Haraf DJ, Hoffman PC, Watson SM, Golomb HM, Vokes EE. Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol. 1998 Jan; 16(1):159-64. PMID: 9440738.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    47. Vokes EE, Mauer AM, Hoffman PC, Masters G, Watson S, Golomb HM, Vokes EE, Mauer AM, Hoffman PC, Masters G, Watson S, Golomb HM. Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-67-S12-69. PMID: 9331125.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    48. Vokes EE, Masters GA, Mauer AM, Haraf DJ, Hoffman PC, Golomb HM, Vokes EE, Masters GA, Mauer AM, Haraf DJ, Hoffman PC, Golomb HM. Clinical studies of docetaxel (Taxotere) and concomitant chest therapy. Semin Oncol. 1997 Aug; 24(4 Suppl 14):S14-26-S14-29. PMID: 9335521.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    49. Lauria MM, Hockenberry-Eaton M, Pawletko TM, Mauer AM, Lauria MM, Hockenberry-Eaton M, Pawletko TM, Mauer AM. Psychosocial protocol for childhood cancer. A conceptual model. Cancer. 1996 Sep 15; 78(6):1345-56. PMID: 8826961.
      Citations: 2     Fields:    Translation:Humans
    50. Miller AA, Mauer AM, Tolley EA, Miller AA, Mauer AM, Tolley EA. Dosing of oral etoposide normalized for body surface area. Cancer Invest. 1995; 13(5):487-91. PMID: 7552815.
      Citations:    Fields:    Translation:Humans
    51. Miller AA, Tolley EA, Niell HB, Griffin JP, Mauer AM, Miller AA, Tolley EA, Niell HB, Griffin JP, Mauer AM. Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer. J Clin Oncol. 1993 Jun; 11(6):1179-88. PMID: 8388920.
      Citations: 9     Fields:    Translation:Humans
    52. Mauer AM, Mauer AM. Adult and childhood acute lymphocytic leukemia: are they different diseases? Am J Hematol. 1993 Jan; 42(1):127-31. PMID: 8416287.
      Citations:    Fields:    Translation:Humans
    53. Mauer AM, Mauer AM. The biological basis of age in the determination of prognosis in acute lymphoblastic leukemia. Cancer Invest. 1989; 7(6):601-5. PMID: 2630009.
      Citations:    Fields:    Translation:Humans
    54. Mauer AM, Mauer AM. Acute lymphoblastic leukemia in a young adult. Hosp Pract (Off Ed). 1987 Sep 15; 22(9):145-50, 155-62. PMID: 3114285.
      Citations:    Fields:    Translation:Humans
    55. Hunter RF, Broadway P, Sun SL, Niell HB, Mauer AM, Hunter RF, Broadway P, Sun SL, Niell HB, Mauer AM. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation. Cancer Res. 1987 May 15; 47(10):2737-40. PMID: 3032414.
      Citations: 3     Fields:    Translation:Humans
    56. Mauer AM, Mauer AM. New directions in the treatment of acute lymphoblastic leukemia in children. N Engl J Med. 1986 Jul 31; 315(5):316-7. PMID: 3459963.
      Citations: 4     Fields:    Translation:Humans
    57. George SL, Ochs JJ, Mauer AM, Simone JV, George SL, Ochs JJ, Mauer AM, Simone JV. The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol. 1985 Jun; 3(6):776-81. PMID: 3891922.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    58. Thompson EI, Callihan TR, Mauer AM, Thompson EI, Callihan TR, Mauer AM. Prophylaxis in severe granulocytopenia. Adv Intern Med. 1984; 29:193-214. PMID: 6369925.
      Citations:    Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    59. Look AT, Melvin SL, Williams DL, Brodeur GM, Dahl GV, Kalwinsky DK, Murphy SB, Mauer AM, Look AT, Melvin SL, Williams DL, Brodeur GM, Dahl GV, Kalwinsky DK, Murphy SB, Mauer AM. Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood. 1982 Oct; 60(4):959-67. PMID: 7115962.
      Citations: 21     Fields:    Translation:HumansCells
    60. Dahl GV, Kalwinsky DK, Murphy S, Look AT, Amadori S, Kumar M, Novak R, George SL, Mason C, Mauer AM, Simone JV, Dahl GV, Kalwinsky DK, Murphy S, Look AT, Amadori S, Kumar M, Novak R, George SL, Mason C, Mauer AM, Simone JV. Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood. 1982 Oct; 60(4):856-63. PMID: 6896834.
      Citations: 4     Fields:    Translation:Humans
    61. Evans WE, Tsiatis A, Rivera G, Murphy SB, Dahl GV, Denison M, Crom WR, Barker LF, Mauer AM, Evans WE, Tsiatis A, Rivera G, Murphy SB, Dahl GV, Denison M, Crom WR, Barker LF, Mauer AM. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer. 1982 Apr 01; 49(7):1378-83. PMID: 7037164.
      Citations: 17     Fields:    Translation:HumansCells
    62. Murphy SB, Dahl GV, George SL, Karas J, Look AT, Simone JV, Mauer AM, Murphy SB, Dahl GV, George SL, Karas J, Look AT, Simone JV, Mauer AM. Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia. Leuk Res. 1982; 6(5):639-48. PMID: 7154706.
      Citations: 1     Fields:    Translation:Humans
    63. Ackerman TF, Mauer AM, Ackerman TF, Mauer AM. Sounding board. Compensation and cancer research. N Engl J Med. 1981 Sep 24; 305(13):760-3. PMID: 7022217.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    64. Brodeur GM, Pratt CB, Mauer AM, Brodeur GM, Pratt CB, Mauer AM. Case 50-1980: mixed malignant germ-cell tumor. N Engl J Med. 1981 Apr 23; 304(17):1047-8. PMID: 6259530.
      Citations:    Fields:    Translation:Humans
    65. George SL, Aur RJ, Mauer AM, Simone JV, George SL, Aur RJ, Mauer AM, Simone JV. A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med. 1979 Feb 08; 300(6):269-73. PMID: 282457.
      Citations: 23     Fields:    Translation:Humans
    66. Rivera G, Murphy SB, Aur RJ, Verzosa MS, Dahl GV, Mauer AM, Rivera G, Murphy SB, Aur RJ, Verzosa MS, Dahl GV, Mauer AM. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission. Cancer. 1978 Dec; 42(6):2521-8. PMID: 282003.
      Citations: 2     Fields:    Translation:Humans
    67. Pratt CB, Smith JW, Woerner S, Mauer AM, Hustu HO, Johnson WW, Shanks EC, Pratt CB, Smith JW, Woerner S, Mauer AM, Hustu HO, Johnson WW, Shanks EC. Factors leading to delay in the diagnosis and affecting survival of children with head and neck rhabdomyosarcoma. Pediatrics. 1978 Jan; 61(1):30-4. PMID: 263871.
      Citations: 4     Fields:    Translation:Humans
    68. Hayes FA, Green AA, Mauer AM, Hayes FA, Green AA, Mauer AM. Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res. 1977 Oct; 37(10):3766-70. PMID: 908020.
      Citations: 8     Fields:    Translation:Humans
    69. Mauer AM, Mauer AM. Recent advances in pediatric oncology. Pediatr Res. 1977 Sep; 11(9 Pt 2):1008-10. PMID: 198732.
      Citations:    Fields:    Translation:Humans
    70. Murphy SB, Mauer AM, Murphy SB, Mauer AM. Terminal transferase and lymphoblastic neoplasms. N Engl J Med. 1977 Sep 01; 297(9):502-3. PMID: 267806.
      Citations:    Fields:    Translation:Humans
    71. Mauer AM, Murphy SB, Hayes FA, Mauer AM, Murphy SB, Hayes FA. Evidence for recruitment and synchronization in leukemia and solid tumors. Cancer Treat Rep. 1976 Dec; 60(12):1841-4. PMID: 1026338.
      Citations:    Fields:    Translation:Humans
    72. Hayes FA, Mauer AM, Hayes FA, Mauer AM. Cell kinetics and chemotherapy in neuroblastoma. J Natl Cancer Inst. 1976 Sep; 57(3):697-9. PMID: 978773.
      Citations:    Fields:    Translation:HumansCells
    73. Lampkin BC, McWilliams NB, Mauer AM, Flessa HC, Hake DA, Fisher V, Lampkin BC, McWilliams NB, Mauer AM, Flessa HC, Hake DA, Fisher V. Manipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia. Br J Haematol. 1976 Jan; 32(1):29-40. PMID: 1063031.
      Citations: 6     Fields:    Translation:Humans
    74. Mauer AM, Murphy SB, Mauer AM, Murphy SB. Cell kinetics and practical consequences for therapy of acute leukemia. Proc Inst Med Chic. 1975 Jul-Sep; 30(8):247-50. PMID: 1187606.
      Citations:    Fields:    Translation:Humans
    75. Strauss RG, Bove KE, Jones JF, Mauer AM, Fulginiti VA, Strauss RG, Bove KE, Jones JF, Mauer AM, Fulginiti VA. An anomaly of neutrophil morphology with impaired function. N Engl J Med. 1974 Feb 28; 290(9):478-84. PMID: 4129798.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    76. Mauer AM, Lampkin BC, McWilliams NB, Mauer AM, Lampkin BC, McWilliams NB. Effects of chemotherapeutic agents on cell cycle and cellular proliferation: basic and clinical considerations. Transplant Proc. 1973 Sep; 5(3):1181-4. PMID: 4517030.
      Citations:    Fields:    Translation:HumansCells
    77. Lampkin BC, McWilliams NB, Mauer AM, Lampkin BC, McWilliams NB, Mauer AM. Cell kinetics and chemotherapy in acute leukemia. Semin Hematol. 1972 Apr; 9(2):211-23. PMID: 4502317.
      Citations: 2     Fields:    Translation:HumansCells
    78. Lampkin BC, Nagao T, Mauer AM, Lampkin BC, Nagao T, Mauer AM. Synchronization and recruitment in acute leukemia. J Clin Invest. 1971 Oct; 50(10):2204-14. PMID: 5286686; PMCID: PMC292155.
      Citations: 12     Fields:    Translation:HumansCells
    79. Wriedt K, Kauder E, Mauer AM, Wriedt K, Kauder E, Mauer AM. Defective myelopoiesis in congenital neutropenia. N Engl J Med. 1970 Nov 12; 283(20):1072-7. PMID: 5470848.
      Citations: 5     Fields:    Translation:HumansCells
    80. Nagao T, Mauer AM, Nagao T, Mauer AM. Concordance for drug-induced aplastic anemia in identical twins. N Engl J Med. 1969 Jul 03; 281(1):7-11. PMID: 5785754.
      Citations: 17     Fields:    Translation:HumansCells
    81. Canales ML, Mauer AM, Canales ML, Mauer AM. Sex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich syndrome. N Engl J Med. 1967 Oct 26; 277(17):899-901. PMID: 4168739.
      Citations: 13     Fields:    Translation:HumansCells
    82. Saunders EF, Lampkin BC, Mauer AM, Saunders EF, Lampkin BC, Mauer AM. Variation of proliferative activity in leukemic cell populations of patients with acute leukemia. J Clin Invest. 1967 Aug; 46(8):1356-63. PMID: 16695924; PMCID: PMC297137.
      Citations: 16     Fields:    
    83. Lampkin BC, Mauer AM, McBride BH, Lampkin BC, Mauer AM, McBride BH. Response of medulloblastoma to vincristine sulfate: a case report. Pediatrics. 1967 May; 39(5):761-3. PMID: 6026877.
      Citations: 7     Fields:    Translation:Humans
    84. Mauer AM, Fisher V, Mauer AM, Fisher V. Characteristics of cell proliferation in four patients with untreated acute leukemia. Blood. 1966 Sep; 28(3):428-45. PMID: 5223200.
      Citations: 13     Fields:    Translation:Humans
    85. KRILL CE, SMITH HD, MAUER AM, KRILL CE, SMITH HD, MAUER AM. CHRONIC IDIOPATHIC GRANULOCYTOPENIA. N Engl J Med. 1964 May 07; 270:973-9. PMID: 14122792.
      Citations: 18     Fields:    Translation:Humans
    Mauer's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (349)
    Explore
    _
    Co-Authors (25)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _